Yamamoto, Keisuke
Venida, Anthony
Yano, Julian
Biancur, Douglas E.
Kakiuchi, Miwako
Gupta, Suprit
Sohn, Albert S. W.
Mukhopadhyay, Subhadip
Lin, Elaine Y.
Parker, Seth J.
Banh, Robert S.
Paulo, Joao A.
Wen, Kwun Wah
Debnath, Jayanta http://orcid.org/0000-0002-8745-4069
Kim, Grace E.
Mancias, Joseph D.
Fearon, Douglas T.
Perera, Rushika M.
Kimmelman, Alec C.
Article History
Received: 27 August 2019
Accepted: 28 March 2020
First Online: 22 April 2020
Change Date: 13 May 2020
Change Type: Update
Change Details: Source Data files for figures and extended data figures were uploaded.
Competing interests
: A.C.K. has financial interests in Vescor Therapeutics, LLC. A.C.K. is an inventor on patents pertaining to KRAS-regulated metabolic pathways, redox control pathways in pancreatic cancer, targeting GOT1 as a therapeutic approach, and the autophagic control of iron metabolism. A.C.K. is on the SAB of Rafael/Cornerstone Pharmaceuticals. A.C.K. is a consultant for Deciphera. J.D. is on the Scientific Advisory Board of Vescor Therapeutics, LLC. The other authors declare no competing interests.